Retraction to: Cancer Gene Therapy
https://doi.org/10.1038/cgt.2015.6 published online 27 February 2015
The Editor-in-Chief is retracting this article [1]. Concerns were raised that the MALAT2 gene described does not exist. This has been confirmed by post-publication peer review: there is only one transcript, which is called MALAT1. None of the authors has responded to correspondence from the Editor-in-Chief or the Publisher about this retraction.
Reference
Chen F, Tian Y, Pang E, Wang Y, Li L. MALAT2-activated long noncoding RNA indicates a biomarker of poor prognosis in gastric cancer. Cancer Gene Ther. 2015; https://doi.org/10.1038/cgt.2015.6.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Chen, F., Tian, Y., Pang, Ej. et al. Retraction Note: MALAT2-activated long noncoding RNA indicates a biomarker of poor prognosis in gastric cancer. Cancer Gene Ther 27, 514 (2020). https://doi.org/10.1038/s41417-020-0177-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41417-020-0177-8
